Presentation is loading. Please wait.

Presentation is loading. Please wait.

Economic evaluation of highly purified menotropin compared with recombinant follicle- stimulating hormone in assisted reproduction  Adam Lloyd, M.Phil.,

Published byGusztáv Tamás Modified over 5 years ago

Similar presentations

Presentation on theme: "Economic evaluation of highly purified menotropin compared with recombinant follicle- stimulating hormone in assisted reproduction  Adam Lloyd, M.Phil.,"— Presentation transcript:

1 Economic evaluation of highly purified menotropin compared with recombinant follicle- stimulating hormone in assisted reproduction  Adam Lloyd, M.Phil., Richard Kennedy, M.B.Ch.B., D.A., F.R.C.O.G., Julia Hutchinson, M.Sc., Will Sawyer, Ph.D.  Fertility and Sterility  Volume 80, Issue 5, Pages (November 2003) DOI: /S (03)02185-X

2 Figure 1 Sequence of visits associated with assisted reproduction in the study. Lloyd. Economics of assisted reproduction. Fertil Steril 2003. Fertility and Sterility  , DOI: ( /S (03)02185-X)

3 Figure 2 Sensitivity analysis of the relationship between discount rates for study medication and cost per cycle. Lloyd. Economics of assisted reproduction. Fertil Steril 2003. Fertility and Sterility  , DOI: ( /S (03)02185-X)

Download ppt "Economic evaluation of highly purified menotropin compared with recombinant follicle- stimulating hormone in assisted reproduction  Adam Lloyd, M.Phil.,"

Similar presentations

What’s the delay? A qualitative study of women’s experiences of reaching a diagnosis of endometriosis  Karen Ballard, Ph.D., Karen Lowton, Ph.D., Jeremy.

What’s the delay? A qualitative study of women’s experiences of reaching a diagnosis of endometriosis  Karen Ballard, Ph.D., Karen Lowton, Ph.D., Jeremy.
HP-HMG versus rFSH in treatments combining fresh and frozen IVF cycles: success rates and economic evaluation  Jaro Wex-Wechowski, Ahmed M. Abou-Setta,

HP-HMG versus rFSH in treatments combining fresh and frozen IVF cycles: success rates and economic evaluation  Jaro Wex-Wechowski, Ahmed M. Abou-Setta,
Evaluation of basal estradiol levels in assisted reproductive technology cycles2  John L Frattarelli, M.D., Paul A Bergh, M.D., Michael R Drews, M.D.,

Evaluation of basal estradiol levels in assisted reproductive technology cycles2  John L Frattarelli, M.D., Paul A Bergh, M.D., Michael R Drews, M.D.,
The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition  Lorraine Dennerstein,

The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition  Lorraine Dennerstein,
Bjørn Bay, M. D. , Erik Lykke Mortensen, M. Sc

Bjørn Bay, M. D. , Erik Lykke Mortensen, M. Sc
The predictive value for in vitro fertility delivery rates is greatly impacted by the method used to select the threshold between normal and elevated.

The predictive value for in vitro fertility delivery rates is greatly impacted by the method used to select the threshold between normal and elevated.
Michael M. Alper, M.D.  Fertility and Sterility 

Michael M. Alper, M.D.  Fertility and Sterility 
Janet Kwee, M. D. , Roel Schats, M. D. , Ph. D. , Joseph McDonnell, M

Janet Kwee, M. D. , Roel Schats, M. D. , Ph. D. , Joseph McDonnell, M
The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation.

The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation.
A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer 

A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer 
Neohormones as biomarkers of reproductive health

Neohormones as biomarkers of reproductive health
Growth rates of ovarian follicles during natural menstrual cycles, oral contraception cycles, and ovarian stimulation cycles  Angela R. Baerwald, Ph.D.,

Growth rates of ovarian follicles during natural menstrual cycles, oral contraception cycles, and ovarian stimulation cycles  Angela R. Baerwald, Ph.D.,
Follicular-phase ovarian follicular fluid and plasma cytokine profiling of natural cycle in vitro fertilization patients  N. Ellissa Baskind, M.B.Ch.B.,

Follicular-phase ovarian follicular fluid and plasma cytokine profiling of natural cycle in vitro fertilization patients  N. Ellissa Baskind, M.B.Ch.B.,
Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging  Siobán D. Harlow,

Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging  Siobán D. Harlow,
Antimüllerian hormone levels and antral follicle count as prognostic indicators in a personalized prediction model of live birth  Scott M. Nelson, M.R.C.O.G.,

Antimüllerian hormone levels and antral follicle count as prognostic indicators in a personalized prediction model of live birth  Scott M. Nelson, M.R.C.O.G.,
Hongxia Li, M. D. , Jiangang Chen, M. D. , James W Overstreet, M. D

Hongxia Li, M. D. , Jiangang Chen, M. D. , James W Overstreet, M. D
Medical treatment of ectopic pregnancy: a committee opinion

Medical treatment of ectopic pregnancy: a committee opinion
Follicle-stimulating hormone administered at the time of human chorionic gonadotropin trigger improves oocyte developmental competence in in vitro fertilization.

Follicle-stimulating hormone administered at the time of human chorionic gonadotropin trigger improves oocyte developmental competence in in vitro fertilization.
A differential cytokine expression profile is induced by highly purified human menopausal gonadotropin and recombinant follicle-stimulating hormone in.

A differential cytokine expression profile is induced by highly purified human menopausal gonadotropin and recombinant follicle-stimulating hormone in.
The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society.

The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society.

Similar presentations

Ads by Google